40164_2020_160_MOESM1_ESM.docx (721.72 kB)
Additional file 1 of Indirect comparison of azacitidine and decitabine for the therapy of elderly patients with acute myeloid leukemia: a systematic review and network meta-analysis
journal contribution
posted on 2020-03-17, 04:39 authored by Bingbing Wen, Weiwen You, Sitian Yang, Xin DuAdditional file 1: Figure S1. Azacitidine vs. conventional care regimens (direct evidence-RR). Figure S2. Azacitidine vs. conventional care regimens (direct evidence-OR). Figure S3. Decitabine vs. conventional care regimens (direct evidence-RR). Figure S4. Decitabine vs. conventional care regimens (direct evidence-OR). Table S1. Azacitidine compared to CCR for elderly patients diagnosed with AML. Table S2. Decitabine compared to CCR for elderly patients diagnosed with AML. Table S3. Azacitidine compared to decitabine for elderly patients diagnosed with AML. Table S4. Search strategies.